2020

1. Correction to: Once‑Monthly Long‑Acting Injectable Aripiprazole for the Treatment of Patients with Schizophrenia and Co‑occurring Substance Use Disorders: A Multicentre, Observational Study (Drugs - Real World Outcomes, (2020), 7, 1, (75-83), 10.1007/s40801-020-00178-8)

   Drugs - Real World Outcomes

2. Once-Monthly Long-Acting Injectable Aripiprazole for the Treatment of Patients with Schizophrenia and Co-occurring Substance Use Disorders: A Multicentre, Observational Study

   Drugs - Real World Outcomes, Vol. 7, Núm. 1, pp. 75-83